Ramoda, MB

Company age: 5 y. 3 mo.

Update

Company overview

Company name Ramoda, MB
Company code 305802726
VAT code LT100014176419
Registered address Marijampolės sav., Liudvinavo sen., Želsvos k., Želsvelės g. 3-15, LT-69193
Registration date 2021-06-17 Company age: 5 y. 3 mo.
Phone Phone
Email Email
Website None
Revenue (2025) 137,849 € +49% History
Profit (2025) -7,323 € History
Number of employees 0
Managed vehicles 1 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Retail sale of pharmaceutical products
Ownership form Private without foreign capital

Download a detailed company report

Make confident decisions with all the information about Ramoda, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Ramoda, MB (company code 305802726) is an operational private small partnership registered in 2021. It is classified as a micro-sized company in the sector of national private non-financial companies, under private ownership with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. The company is governed by a CEO only. Its registered address is Želsveles g. 3-15, Želsvos k., Liudvinavo sen., Marijampoles sav., Marijampoles apskr., Lithuania. The company’s activity is retail sale of pharmaceutical products (EVRK G.47.73.00).

Financially, the company generated revenue of €286.5K in 2023 and posted net profit of €16.3K, with a profit margin of 5.7%. In 2024, revenue declined to €92.6K and the company reported a net loss of €9.0K. In 2025, revenue recovered to €137.8K, but the company still recorded a net loss of €7.3K, with a profit margin of -5.3%. Over the latest financial year, revenue increased year on year, although it remained below the 2023 level. Equity was negative in 2024 and 2025, while liabilities exceeded assets in the latest year.